Quick Listen: Scrip’s Five Must-Know Things

 
• By Ian Haydock

In this week's episode: Zepbound bests Wegovy; Novartis and PTC’s Huntingdon’s deal; Vabysmo hopes to ride new listing, data in Asia; Leo Pharma gains momentum; and Immunic’s hopes for MS drug.

Scrip Five Must Know Things
weekly audio roundup of selected content from Scrip's global team

More from Scrip's Five Must-Know Things

More from Business